Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-09-14

Clinical Trial Update: Postoperative Antibiotics Following Primary and Secondary Breast Augmentation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating postoperative antibiotics after breast augmentation was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, Los Angeles | Conditions: Surgical Site Infection, Capsular Contracture Associated With Breast Implant | Phase 4 | Status: WITHDRAWN